ITERUM THERAPEUTICS
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives. It aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive, and anaerobic bacteria resistant to other antibiotics.
ITERUM THERAPEUTICS
Social Links:
Industry:
Medical Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.iterumtx.com
Total Employee:
11+
Status:
Active
Contact:
+353 1 903 8920
Total Funding:
193.4 M USD
Technology used in webpage:
ReCAPTCHA COVID-19 ReCAPTCHA V2 Amazon S3 Ireland Domain Redirect ON24
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
LENZ Therapeutics
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Sarissa Capital Management
Sarissa Capital Management investment in Post-IPO Equity - Iterum Therapeutics
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Iterum Therapeutics
CARB-X
CARB-X investment in Grant - Iterum Therapeutics
Canaan Partners
Canaan Partners investment in Series B - Iterum Therapeutics
Advent Life Sciences
Advent Life Sciences investment in Series B - Iterum Therapeutics
Bay City Capital
Bay City Capital investment in Series B - Iterum Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Iterum Therapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series B - Iterum Therapeutics
Arix Bioscience
Arix Bioscience investment in Series B - Iterum Therapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Iterum Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-13 | Iterum Therapeutics Appoints Sailaja Puttagunta, MD as Chief Medical Officer |
Official Site Inspections
http://www.iterumtx.com Semrush global rank: 3.78 M Semrush visits lastest month: 3.56 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Iterum Therapeutics"
Career Opportunities :: Iterum Therapeutics plc (ITRM)
If you are interested in an organization that is entrepreneurial, collaborative, and driven toward success, we invite you to apply today. To apply for an open position, please select a job title …See details»
Management Team Company Overview
[email protected] Management Team Corey N. Fishman Chief Executive Officer Judith M. Matthews Chief Financial Officer Tom Loughman, PhD Senior Vice President, Technical …See details»
Iterum Therapeutics - Crunchbase Company Profile & Funding
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives. It aimed at combatting the global crisis of multi-drug resistant …See details»
FAQ :: Iterum Therapeutics plc (ITRM)
For investor related questions please send an email to [email protected]. How can I sign up to receive Iterum Therapeutics plc's press releases and other company information? Please visit …See details»
Iterum Therapeutics to Report Third Quarter 2024 Financial Results …
Nov 11, 2024 For more information, please visit www.iterumtx.com. Investor Contact: Judy Matthews Chief Financial Officer 312-778-6073 [email protected]. Source: Iterum …See details»
Iterum Therapeutics Reports Third Quarter 2024 Financial Results
Nov 14, 2024 -ORLYNVAH TM Approved by FDA on October 25, 2024—--Company to Host Conference Call Today at 8:30 a.m. EDT--DUBLIN and CHICAGO, Nov. 14, 2024 (GLOBE …See details»
Iterum Therapeutics Regains Full Nasdaq Compliance
Nov 21, 2024 Iterum will Continue to be Listed and Traded on the Nasdaq Stock Market. DUBLIN and CHICAGO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc …See details»
Our Challenge :: Iterum Therapeutics plc (ITRM)
The World Health Organization (WHO) produced its Global Priority Pathogen List of resistant bacteria. Its authors stressed the importance for oral formulations of new antibiotics for …See details»
Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors
Mar 16, 2021 “As Iterum transitions from a development company to a commercial organization, we are looking forward to leveraging Beth’s diverse pharmaceutical experiences and …See details»
About the Grand Lodge | Grand Lodge of Texas - IOOF
The Grand Lodge of Texas was incorporated in 1877 and is a 501c(8) non-profit organization. In addition to overseeing the operation of the Texas Odd Fellow Lodges, the Grand Lodge of …See details»
X-Team’s Amit Sion, on How to Build High-Retention Culture
Nov 18, 2024 Reflecting over this conversation and thinking about how wonderful it is that you work at an organization that has spent almost two decades intentionally crafting culture that …See details»
History of IOOF | Grand Lodge of Texas - IOOF
The signs and symbols used by Odd Fellowship over the past 200 plus years have been found in Egyptian tombs and in Roman temples in the same arrangements that we use them today. …See details»
News - Iterum Therapeutics plc
Mar 9, 2023 DUBLIN, Ireland and CHICAGO, March 09, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company …See details»
Investors - Iterum Therapeutics plc
Mar 21, 2022 To access the call please dial 844-200-6205 (domestic) or 929-526-1599 (international) and refer to Access Code 096194. The audio webcast can be accessed under …See details»
Inside Remi Ishizuka's Zen Texas Ranch - domino
Nov 19, 2024 Ishizuka: We use the desk area as a workspace (it’s where I store my printer).Every night after dinner we like to sit on the couch, watch TV, and wind down there. …See details»
Iterum Therapeutics to Provide Business Update and Report Third …
To access the call please dial 844-200-6205 (domestic) or 929-526-1599 (international) and refer to Access Code 442364. The audio webcast can be accessed under “Financials & Filings” in …See details»
Rising to the Moment: Responding to Central Texas Needs During ...
6 days ago Whether the mission is to provide laundry services for those who are experiencing homelessness, or if an organization is intended to provide pre-and postnatal care to under …See details»
Iterum Therapeutics to Present Data at IDWeek 2024
DUBLIN and CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next …See details»
Iterum Therapeutics to Participate at the 2024 Maxim Healthcare …
DUBLIN and CHICAGO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next …See details»